Immunotherapy drug did not increase surgery complications, study finds
Researchers recently published study results showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
Materials provided by University of Cincinnati. Original written by Tim Tedeschi. Note: Content may be edited for style and length.
Source link aaaaa